Gsk Plc

Holdings as of Jun 30, 2026 · filed Aug 13, 2026

$602220442
Portfolio value
13
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Crispr Therapeutics Ag $175652997 29.17% Held
2 Wave Life Sciences Ltd $106007465 17.60% Held
3 Vir Biotechnology Inc $87134221 14.47% Held
4 Biontech Se $82798123 13.75% Held
5 Ideaya Biosciences Inc $49693321 8.25% Held
6 Cytokinetics Inc $29001573 4.82% Held
7 Lyell Immunopharma Inc $21252859 3.53% Held
8 Spero Therapeutics Inc $20311239 3.37% Held
9 Nkarta Inc $8916572 1.48% Held
10 Fulcrum Therapeutics Inc $6535713 1.09% Held
11 Bicycle Therapeutics Plc $6485339 1.08% Held
12 Cvrx Inc $5178977 0.86% Held
13 Regenxbio Inc $3252043 0.54% Held

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.